Australia's CSL on track for worst week in 8 months on forecast cut, impairments

Csl

15/05/2026 02:41

** Shares of CSL CSL.AX up 0.8% at A$98.08

** Stock on track for a weekly drop of 18.2%, its biggest drop since mid-August

** Biotech major on Monday trimmed it fiscal 2026 earnings and revenue forecasts; flags $5 billion of non-cash impairments over FY26-27

** Attributes forecast downgrade to delays in payoff from growth initiatives and revenue headwinds from U.S. immunoglobulin inventory normalisation

** Shares fell nearly 16% on Monday

** CSL down 43.2% YTD, including the day's moves

 (Reporting by Nikita Maria Jino in Bengaluru)

 ((Nikita.Jino@thomsonreuters.com;))